Accessibility Menu
 
Avicanna logo

Avicanna

(TSX) AVCN

Current Price$0.15
Market Cap$18.85M
Since IPO (2019)-98%
5 Year-85%
1 Year-35%
1 Month-6%

Avicanna Financials at a Glance

Market Cap

$18.85M

Revenue (TTM)

$25.48M

Net Income (TTM)

$2.93M

EPS (TTM)

$-0.02

P/E Ratio

-6.07

Dividend

$0.00

Beta (Volatility)

1.04 (Average)

Price

$0.15

Volume

140,560

Open

$0.15

Previous Close

$0.15

Daily Range

$0.14 - $0.15

52-Week Range

$0.14 - $0.31

AVCN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Avicanna

Industry

Pharmaceuticals

Employees

80

CEO

Aras Azadian, MBA

Headquarters

Toronto, ON M5G 1V2, CA

AVCN Financials

Key Financial Metrics (TTM)

Gross Margin

52%

Operating Margin

-11%

Net Income Margin

-12%

Return on Equity

-110%

Return on Capital

-23%

Return on Assets

-14%

Earnings Yield

-16.47%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$18.85M

Shares Outstanding

125.68M

Volume

140.56K

Short Interest

0.00%

Avg. Volume

58.98K

Financials (TTM)

Gross Profit

$12.84M

Operating Income

$2.72M

EBITDA

$1.97M

Operating Cash Flow

$1.18M

Capital Expenditure

$255.87K

Free Cash Flow

$1.44M

Cash & ST Invst.

$280.63K

Total Debt

$0.00

Avicanna Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$6.60M

-0.3%

Gross Profit

$3.49M

+1.3%

Gross Margin

52.93%

N/A

Market Cap

$18.85M

N/A

Market Cap/Employee

$216.69K

N/A

Employees

87

N/A

Net Income

$925.28K

-803.5%

EBITDA

$619.73K

-279.7%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$280.63K

-17.2%

Accounts Receivable

$3.55M

+29.0%

Inventory

$3.85M

-3.2%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-13.81%

N/A

Return on Invested Capital

-22.90%

N/A

Free Cash Flow

$198.93K

+63.7%

Operating Cash Flow

$191.05K

+20.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GWAY.CNGreenway Greenhouse Cannabis Corporation
$0.15-3.23%
VM.VVoyageur Pharmaceuticals Ltd.
$0.12+0.00%
IZO.CNIzotropic Corporation
$0.23-0.00%
LABS.TOMediPharm Labs Corp.
$0.07+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
EFOIEnergy Focus
$6.49+2.11%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.90+0.06%
NFLXNetflix
$97.31-0.10%
TQQQProShares Trust - ProShares UltraPro Qqq
$58.59+0.04%

Questions About AVCN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.